Abstract

Cardiac resynchronization therapy (CRT) has been shown to consistently improve cardiac performance and exercise capacity, leading to reversal of cardiac remodeling and improvement in survival in patients with advanced heart failure and a significant ventricular conduction delay. The strategy of CRT for the treatment of advanced heart failure was secured in 2005 by the landmark Cardiac Resynchronization in Heart Failure (CARE-HF) study.1 Recently, 2 studies have extended these observed benefits of CRT to patients with less advanced (New York Heart Association [NYHA] class I/II) signs and symptoms who still fulfilled standard indications for resynchronization therapy. The recently published Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT) study demonstrated 34% relative risk reduction in death or heart failure events with CRT and defibrillator (CRT-D) compared with implantable cardioverter-defibrillator alone in 1820 subjects with left ventricular (LV) ejection fraction ≤30% and QRS duration ≥130 ms, which was largely driven by reduction in heart failure events and associated with reverse remodeling.2 Although the primary end point of a heart failure clinical composite response was not met in the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) trial, observed improvement in the prospectively powered secondary end point of LV end-systolic volume index in the presence of CRT suggests that early implementation of CRT±D in 610 patients with mild heart failure (NYHA class I/II, LV ejection fraction ≤40% and LV end-diastolic dimension ≥55 mm by echocardiography, QRS duration ≥120 ms) may be considered a beneficial strategy.3 The article by St John Sutton and colleagues4 extends the concept of reverse remodeling of CRT by carefully examining the time course of reverse remodeling and identifying the subgroups that may have a particularly favorable response. The investigators now provide a more …

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.